CTSH Q3 2025 Earnings Call Summary | Stock Taper
Logo
CTSH

CTSH — Cognizant Technology Solutions Corporation

NASDAQ


Q3 2025 Earnings Call Summary

October 29, 2025

Summary of Cognizant Technology Solutions (CTSH) Q3 2025 Earnings Call

1. Key Financial Results and Metrics

  • Revenue: $5.4 billion, up 6.5% year-over-year in constant currency.
  • Adjusted Operating Margin: Improved by 70 basis points year-over-year to 16%.
  • Adjusted EPS: Grew approximately 11% to $1.39, excluding a one-time tax expense of $0.80 per share.
  • Bookings: Trailing 12-month bookings increased by 5%, with a book-to-bill ratio of 1.3x. However, Q3 bookings declined by about 5% year-over-year.
  • Free Cash Flow: $1.2 billion, representing 170% of adjusted net income.
  • Return to Shareholders: $1.5 billion year-to-date, with a plan to return $2 billion in 2025.

2. Strategic Updates and Business Highlights

  • Cognizant is evolving into an "AI builder," focusing on integrating AI across its operations and client services.
  • The company signed 6 large deals (TCV of $100 million+) in Q3, totaling 16 year-to-date.
  • All operating segments achieved organic revenue growth, with Financial Services leading due to increased spending on digital engineering and generative AI.
  • The company is investing in upskilling its workforce, with 30% of internal code now AI-generated.
  • Partnerships with firms like Anthropic and Google Gemini Enterprise are enhancing Cognizant's AI capabilities.

3. Forward Guidance and Outlook

  • Q4 Revenue Guidance: Expected to grow 2.5% to 3.5% year-over-year in constant currency.
  • Full Year Revenue Growth: Revised to 6% to 6.3%, above the previous range of 4% to 6%.
  • Adjusted Operating Margin Guidance: Increased to approximately 15.7%.
  • Adjusted EPS Guidance: Raised to $5.22 to $5.26, reflecting 10% to 11% year-over-year growth.

4. Bad News, Challenges, or Points of Concern

  • Declining Bookings: Despite strong overall performance, there was a 5% year-over-year decline in Q3 bookings, indicating potential headwinds in demand.
  • Geopolitical and Economic Uncertainty: Clients are cautious with technology investments, leading to slower discretionary spending in certain areas.
  • Impact of Inorganic Growth: The acquisition of Belcan contributed to inorganic growth but may dilute margins in the short term.
  • Tax Expense: A one-time noncash income tax expense of $390 million due to changes in U.S. tax policy could impact future earnings.

5. Notable Q&A Insights

  • New Business Pipeline: There is a healthy pipeline for smaller AI-led discretionary projects, alongside large deal momentum.
  • Revenue per Employee: Increased by 8%, indicating improved productivity, driven by a shift towards fixed-price and outcome-based services.
  • Competitive Dynamics: Large deals are becoming less price-sensitive as clients focus on innovation rather than just cost savings.
  • Partnership Strategy: Cognizant is broadening its partnerships beyond traditional software companies to include frontier model companies like OpenAI and Anthropic, aiming to enhance its AI capabilities.
  • Health Care Outlook: The health care vertical remains strong, with BPaaS offerings and AI-led initiatives expected to drive growth despite policy uncertainties.

Overall, Cognizant's Q3 2025 results reflect a strong performance driven by AI integration and strategic investments, though challenges in bookings and economic uncertainty present potential risks moving forward.